MDAI

DALLAS, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today highlighted its participation at the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly, held October 5-8 in Chicago, IL.  The Company showcased its FDA-cleared DeepView™ System for Burn Indication at this year’s Assembly. Widely recognized as the world’s largest emergency medicine conference, the event drew an estimated 7,000 attendees.   "Having the DeepView System on display at this year’s ACEP Scientific Assembly prov

DALLAS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the submission of a New Technology Add-On Payment (NTAP) application to the Centers for Medicare & Medicaid Services (CMS) for its DeepView™ System utilizing the alternative pathway. The NTAP program is designed to provide an additional hospital inpatient payment for eligible procedures involving new technologies or medical services that meet CMS requirements, helping to address the additional costs associated with incorporating innov

DALLAS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of the first Site Initiation Visit ("SIV") associated with the commencement of a clinical study designed to support a label expansion of the Company’s FDA-cleared DeepView System™ for Burn Indication to include burns involving the head, hands and feet. The SIV was conducted at Pinderfields Hospital, Wakefield, UK under the leadership of Principal Investigator Dr. Preetha Muthayya, Consultant Burns and Plastic Surgeon an

4 - Spectral AI, Inc. (0001833498) (Issuer)

4 - Spectral AI, Inc. (0001833498) (Issuer)

DALLAS, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced a scheduled presentation at the upcoming ACS Clinical Congress 2026, being held September 26-29, 2026 in Washington, DC. Entitled "Artificial Intelligence Training & Validation of Multi-Spectral Imaging Device for Evaluation of Burn Wounds," the presentation will be led by James H. Holmes IV, MD, FACS, FABA, Director of the Burn Center at Atrium Health Wake Forest Baptist Medical Center and Professor of Surgery and Regenerative Medic

4 - Spectral AI, Inc. (0001833498) (Issuer)

DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the Southern Regional Burn Conference (SRBC), held September 10-12, 2026 in Williamsburg, Virginia.    The Company’s DeepView® System for Burn Indication was on display for attending burn care clinicians and was the subject of KOL presentations that support the use of AI and multispectral imaging in the assessment of burn wounds:     Artificial Intelligence Evaluation of Multispectral Imaging Impro

8-K - Spectral AI, Inc. (0001833498) (Filer)

4 - Spectral AI, Inc. (0001833498) (Issuer)

DALLAS, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Vincent Capone, Chief Executive Officer, and David McGuire, Chief Financial Officer, are scheduled to present at the H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14−16, 2026 in New York City. "The receipt of FDA De Novo Clearance for our DeepView® System for Burn Indication in May 2026 was the culmination of years of hard work by our dedicated team and a defining moment in Spectral AI’s history," s

4 - Spectral AI, Inc. (0001833498) (Issuer)

SCHEDULE 13G - Spectral AI, Inc. (0001833498) (Subject)

8-K - Spectral AI, Inc. (0001833498) (Filer)

Company Continues to Advance Towards First Commercial Sales of the DeepView® System for Burn Indication Strong Cash Position of $14.0 Million at June 30, 2026 DALLAS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced financial results for the second quarter ended June 30, 2026 ("Q2 2026"). "Spectral AI has entered the second half of 2026 with tremendous momentum and a clear sense of purpose," said Vincent Capone, Chief Executive Officer of Spectral AI. "The receipt of De Novo clearance from the

10-Q - Spectral AI, Inc. (0001833498) (Filer)

DALLAS, July 29, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that it will report financial results for the second quarter ended June 30, 2026 on Tuesday, August 11, 2026, after the close of the Nasdaq stock market. The Company will host a corresponding conference call at 5:00 pm Eastern Time on the same day to discuss its financial results. Investors interested in participating in the live call can dial into the conference call as follows: 833-890-6620 – U.S.412-564-3789 – International In ad

8-K - Spectral AI, Inc. (0001833498) (Filer)

DALLAS, July 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of Darcy Bajko as Chief Commercial Officer, effective July 31, 2026. Ms. Bajko will lead the commercial functions in support of Spectral AI’s global launch of its DeepView® System for burn indication, which was granted De Novo Classification by the U.S. Food and Drug Administration (FDA) in May 2026. "Darcy’s appointment further strengthens our executive team and represents an important step for Spectral AI as we pivot

4 - Spectral AI, Inc. (0001833498) (Issuer)

DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today reflected on its successful participation at the British Burn Association (BBA) Annual Conference, held on June 17th – 19th  at the Nottingham Trent University, Nottingham, England.    The Company’s DeepView® System was on display and was the subject of multiple podium and poster presentations during the conference, highlighting its contributions to advancing burn care through advanced diagnostic analysis across the globe. The presentation fr

DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, is joining the American Board of Wound Management (ABWM) Foundation in celebrating the 10th Annual Wound Healing Awareness Month. In this milestone year, during the month of June the ABWM Foundation will continue its mission of raising awareness, empowering certified wound care specialists, and transforming lives. "Wound Healing Awareness Month is an important reminder that patients living with painful, sometimes complex burn wounds require a timely

DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ:MDAI) ("Spectral AI" or the "Company"), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its participation in the upcoming British Burn Association ("BBA") Annual Meeting, being held June 17-19, 2026 at the Nottingham Trent University, Nottingham, England.    The Company's DeepView® System will be on display at Stand #22 and will be the subject of multiple podium and poster presentations during the conference. This innovative, first-of-its-kind burn wound assessment technology was granted De Novo Classification by the U.S

8-K - Spectral AI, Inc. (0001833498) (Filer)

4 - Spectral AI, Inc. (0001833498) (Issuer)